pentaerythritol tetranitrate has been researched along with Fetal Growth Restriction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodowski, L; Condic, M; de Vries, L; Delius, M; Eckmann-Scholz, C; Friebe-Hoffmann, U; Groten, T; Hoopmann, M; Hübener, C; Jäger, Y; Kagan, KO; Komar, M; Kraft, K; Lato, K; Lehmann, T; Pecks, U; Schlembach, D; Schleußner, E; Schrey-Petersen, S; Seeger, S; Seliger, G; Sroka, D; Städtler, M; Strizek, B; Tauscher, A; Verlohren, S; von Kaisenberg, CS; Winkler, JL | 1 |
| Groten, T; Lehmann, T; Schleußner, E | 1 |
| Bowkalow, S; Groten, T; Kähler, C; Lehmann, T; Schleussner, E; Schneider, U | 1 |
| Groten, T; Kähler, C; Lehmann, T; Schlembach, D; Schleussner, E; Schneider, U | 1 |
4 trial(s) available for pentaerythritol tetranitrate and Fetal Growth Restriction
| Article | Year |
|---|---|
Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trial.
Topics: Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Pentaerythritol Tetranitrate; Perfusion; Perinatal Death; Placenta; Placentation; Pregnancy; Premature Birth | 2023 |
Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial.
Topics: Adult; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, Small for Gestational Age; Outcome Assessment, Health Care; Pentaerythritol Tetranitrate; Perfusion Imaging; Placenta; Placental Insufficiency; Pregnancy; Pregnancy Outcome; Ultrasonography, Doppler; Ultrasonography, Prenatal; Uterine Artery; Vasodilator Agents | 2019 |
Pentaerythrityltetranitrate (PETN) improves utero- and feto-placental Doppler parameters in pregnancies with impaired utero-placental perfusion in mid-gestation - a secondary analysis of the PETN-pilot trial.
Topics: Adult; Double-Blind Method; Drug Monitoring; Female; Fetal Growth Retardation; Fetus; Gestational Age; Humans; Pentaerythritol Tetranitrate; Perfusion Imaging; Placenta; Placenta Diseases; Pregnancy; Treatment Outcome; Ultrasonography, Prenatal; Umbilical Arteries; Uterine Artery; Uterus; Vasodilator Agents | 2018 |
Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial.
Topics: Abruptio Placentae; Double-Blind Method; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Nitric Oxide Donors; Pentaerythritol Tetranitrate; Perinatal Death; Placenta; Placenta Diseases; Placentation; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Premature Birth; Prospective Studies; Ultrasonography, Prenatal; Uterine Artery; Vasodilator Agents | 2014 |